Healthy Volunteers Clinical Trial
Official title:
Hass Avocado Flesh Inhibition of Appearance of Lipid Peroxidation Products When Added to a Ground Beef Patty Consumed by Healthy Volunteers
Avocados are naturally rich in antioxidants, or beneficial compounds, that can help prevent
many diseases, like atherosclerosis (hardening of the arteries). When foods that are high in
fats are eaten, certain harmful compounds can be absorbed, which can lead to atherosclerosis.
One harmful compound is called malondialdehyde, or MDA. This compound can be measured in the
blood and the urine after a person eats a high fat meal. Antioxidants found in herbs and
spices may lower the absorption of MDA, which could help prevent the development of
atherosclerosis.
This study will determine whether the beneficial compounds of avocado can reduce absorption
of MDA. This will be tested by asking healthy males to eat a high fat ground beef patty with
or without avocado and then measuring the amount of MDA in their blood and urine samples.
Blood flow will also be measured. Healthy men have been chosen for this study because eating
high fat hamburger patties can easily mimic in them the condition that causes
atherosclerosis. Avocados are rich in antioxidants, which have been shown in previous studies
to reduce the absorption of harmful compounds, like MDA, that are formed during cooking. The
results from this study may help to explain how high fat foods can be harmful to the body and
how beneficial antioxidants from herbs and spices can protect the body.
This will be determined from blood and urine samples after the subjects are given two
different meals: a) a plain cooked ground beef patty, and b) or avocado with a cooked ground
beef patty.
The Hass Avocado contains monounsaturated fat, lutein, glutathione, vitamin E, and other
antioxidants. This study will determine whether avocado exerts a beneficial effect by
inhibition of the absorption of malondialdehyde (MDA) which is a measure of lipid
peroxidation. In a previous study, we demonstrated that spice antioxidants resulted in a 70
percent decrease in the formation of MDA during cooking and that healthy volunteers consuming
burgers made with spice excreted 50 percent less MDA in their urine than subjects consuming a
control burger made without spices. Since the spices were added during cooking of the burger,
it was not possible to assess the effects of the antioxidants in the stomach. Foods in the
stomach continue to form lipid peroxidation products during digestion and this is called the
"bioreactor" function of the stomach. In the proposed study known quantities of fresh avocado
will be placed on top of a burger prior to consumption to determine whether the avocado
inhibits formation of MDA from cooked burger meat in the stomach. Study demonstrated an
increase in inflammatory and oxidative markers in mononuclear cells using Western blot
analysis of nuclear factor-kappa light chain enhancer of activated B cells (NFkB) and NADPH
oxidase subunits following a mixed high calorie meal. Considering the rich content of
bioactive compounds in the avocado, we therefore selected these methods for the endpoint
determinations as well in this proposed randomized, crossover study.
We will accomplish the following specific aims:
1. To measure plasma and urine malondialdehyde by high performance liquid chromatography
before and over6 hours after consumption of the test burgers with or without fresh
avocado added just prior to consumption.
2. To measure insulin, glucose, triglycerides, tumor necrosis factor alpha (TNF-α),
interleukin 6 (IL-6), Interleukin 8 (IL-8), NFkB activation, nitric oxide and peripheral
arterial tonometry after each test burger.
These studies will add to the evidence that antioxidants in a lipid phase can inhibit
formation and/or absorption of cytotoxic lipid products such as malondialdehyde. Ultimately,
a better understanding of the role of bioactive substances from plant foods such as the
avocado may demonstrate the importance of plant-based antioxidants in human health.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
| Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
| Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
| Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
| Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
| Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
| Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
| Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
| Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
| Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
| Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
| Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
| Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
| Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
| Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
| Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
| Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
| Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |